Hammerson PLC
25 February 2004
For immediate release - Wednesday, 25 February 2004
Hammerson - Sale of London Office Building for £47.7 million
Hammerson plc has today exchanged contracts and completed the sale of 21
Moorfields, London EC2, to The Gertner Family Interests, in partnership with the
Novyon Foundation, realising net sales proceeds of £47.7 million, slightly in
excess of its book value at 31 December 2003.
Built in 1973, 21 Moorfields is a 14,000 m(2) office building, which is let to
Lazard Bros & Co. (who are not currently in occupation) under a lease expiring
in 2008. Hammerson acquired the building in 1992, which now produces a rental
income of £5.6 million per annum. In 2001, Hammerson obtained outline planning
consent to redevelop the site with a new office building of 40,000 m(2).
John Richards, Chief Executive of Hammerson said:
'This sale will release resources for investment in other projects. The group
has a substantial pipeline of future development opportunities both in the
retail and office sectors.'
Fordgate Limited advised the purchasers.
For further information:
John Richards Tel: 020 7887 1000
Chief Executive
Christopher Smith Tel: 020 7887 1019
Director of Corporate Affairs csmith@hammerson.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.